Loading clinical trials...
Loading clinical trials...
A Phase I, 2-panel, Open-label, Randomized, Crossover Trial in Healthy Subjects to Investigate the Pharmacokinetic Interaction Between TMC435 and Transporter Substrates, Digoxin and Rosuvastatin
Conditions
Interventions
Rosuvastatin
Rosuvastatin
+3 more
Start Date
January 1, 2011
Primary Completion Date
May 1, 2011
Completion Date
May 1, 2011
Last Updated
November 30, 2012
NCT05361603
NCT06868264
NCT07388979
NCT05975216
NCT05071261
NCT00894257
Lead Sponsor
Tibotec Pharmaceuticals, Ireland
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions